Towards an integrative approach to the management of myotonic dystrophy type 1

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 78, Issue 8, 2007, Pages 800-806

  Gagnon, Cynthia ^a   Noreau, Luc ^c   Moxley, Richard T ^e   Laberge, Luc ^a   Jean, Stéphane ^a   Richer, Louis ^b   Perron, Michel ^d,f   Veillette, Suzanne ^d   Mathieu, Jean ^a  

^a Centre de readaptation en deficience physique Jonquiere   (Canada)

^b UNIVERSITÉ DU QUÉBEC À CHICOUTIMI   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

^d Groupe ÉCOBES   (Canada)

^e UNIVERSITY OF ROCHESTER   (United States)

^f CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; COMMUNITY HEALTH NURSING; CONCEPTUAL FRAMEWORK; DAILY LIFE ACTIVITY; FAMILY COUNSELING; FOLLOW UP; GENETIC SCREENING; HEALTH CARE PLANNING; HEART ARRHYTHMIA; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; INTERNATIONAL CLASSIFICATION OF IMPAIRMENTS, DISABILITIES AND HANDICAPS; MOTOR ACTIVITY; MYOTONIC DYSTROPHY; MYOTONIC DYSTROPHY TYPE 1; OUTCOME ASSESSMENT; PHENOTYPE; PREGNANCY DISORDER; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SOCIAL SUPPORT;

COMMUNITY HEALTH SERVICES; DISABLED PERSONS; HUMANS; MODELS, THEORETICAL; MYOTONIC DYSTROPHY; PATIENT CARE PLANNING; PATIENT CARE TEAM;

EID: 34547638618     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2006.107185     Document Type: Review

References (94)

1. Mathieu J, De Braekeleer M, Prevost C. Genealogical reconstruction of myotonic dystrophy in the Saguenay-Lac-Saint-Jean area (Quebec, Canada). Neurology 1990;40:839-42.
2. Harper P. Myotonic dystrophy, 3rd edn. London: WB Saunders, 2001.
3. Fu YH, Pizzuti A, Fenwick RG Jr, et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 1992;255:1256-8.
4. Harper P. Myotonic dystrophy: a multisystemic disorder. In: Harper P, Van Engelen B, Eymard B, et al, eds. Myotonic dystrophy:present management, future therapy. Oxford: Oxford University Press, 2004:3-13.
5. Natterlund B, Ahlstrom G. Activities of daily living and quality of life in persons with muscular dystrophy. J Rehabil Med 2001;33:206-11.
6. Perron M, Veillette S, Mathieu J. Myotonic dystrophy: I. Socioeconomic and residential characteristics of the patients. Can J Neurol Sci 1989;16:109-13.
7. Harley HG, Rundle SA, MacMillan JC, et al. Size of the unstable CTG repeat sequence in relation to phenotype and parental transmission in myotonic dystrophy. Am J Hum Genet 1993;52:1164-74.
8. Carey JC. Health supervision and anticipatory guidance for children with genetic disorders (including specific recommendations for trisomy 21, trisomy 18, and neurofibromatosis I). Pediatr Clin North Am 1992;39:25-53.
9. Fowler WM Jr, Carter GT, Kraft GH. The role of physiatry in the management of neuromuscular disease. Phys Med Rehabil Clin N Am 1998;9:1 -8, v.
10. Kinsman SL, Levey E, Ruffing V, et al. Beyond multidisciplinary care: a new conceptual model for spina bifida services. Eur J Pediatr Surg 2000;10(Suppl 1):35-8.
11. WHO. International Classification of Functionning, Disability and Health: ICF. Geneva: WHO, 2001.
12. Fougeyrollas P, Cloutier R, Bergeron H, et al. The Quebec classification: Disability Creation Process. Lac-St-Charles, Quebec: International Network on the Disability Creation Process, 1999.
13. Steiner WA, Ryser L, Huber E, et al. Use of the ICF model as a clinical problem-solving tool in physical therapy and rehabilitation medicine. Phys Ther 2002;82:1098-107.
14. Jette AM, Haley SM, Kooyoomjian JT. Are the ICF activity and participation dimensions distinct? J Rehabil Med 2003;35:145-9.
15. Fougeyrollas P, Beauregard L. Disability: An interactive person-environment social creation. In: Albrecht GL, Seelman KD, Burry M, eds. Handbook of disability studies. London: Sage, 2001:171-94.
16. Dahl TH. International classification of functioning, disability and health: an introduction and discussion of its potential impact on rehabilitation services and research. J Rehabil Med 2002;34:201-4.
17. Fransen J, Uebelhart D, Stucki G, et al. The ICIDH-2 as a framework for the assessment of functioning and disability in rheumatoid arthritis. Ann Rheum Dis 2002;61:225-31.
18. Noreau L, Fougeyrollas P. Long-term consequences of spinal cord injury on social participation: the occurrence of handicap situations. Disabil Rehabil 2000;22:170-80.
19. Desrosiers J, Noreau L, Rochette A. Social participation of older adults in Québec. Aging Clin Exp Res 2004;16:406-12.
20. Desrosiers J, Noreau L, Rochette A, et al. Predictors of handicap situations following post-stroke rehabilitation. Disabil Rehabil 2002;24:774-85.
21. Dubowitz V. Muscle biopsy, 2nd edn. Philadelphia: WB Saunders, 1985.
22. Di Costanzo A, Di Salle F, Santoro L, et al. Brain MRI features of congenital- and adult-form myotonic dystrophy type 1: case-control study. Neuromuscul Disord 2002;12:476-83.
23. Kornblum C, Reul J, Kress W, et al. Cranial magnetic resonance imaging in genetically proven myotonic dystrophy type 1 and 2. J Neurol 2004;251:710-14.
24. Kassubek J, Juengling FD, Hoffmann S, et al. Quantification of brain atrophy in patients with myotonic dystrophy and proximal myotonic myopathy: a controlled 3-dimensional magnetic resonance imaging study. Neurosci Lett 2003;348:73-6.
25. Antonini G, Mainero C, Romano A, et al. Cerebral atrophy in myotonic dystrophy: a voxel based morphometric study. J Neurol Neurosurg Psychiatry 2004;75:1611-3.
26. Meola G, Sansone V, Perani D, et al. Reduced cerebral blood flow and impaired visual-spatial function in proximal myotonic myopathy. Neurology 1999;53:1042-50.
27. Meola G, Sansone V, Perani D, et al. Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1 (DM-1) and in proximal myotonic myopathy (PROMM/DM-2). Neuromuscul Disord 2003;13:813-21.
28. Ono S, Kanda F, Takahashi K, et al. Neuronal loss in the medullary reticular formation in myotonic dystrophy: a clinicopathological study. Neurology 1996;46:228-31.
29. Lassaletta L, Fernandez-Zubilaga A, Gonzalez T, et al. Internal auditory canal hyperostosis in myotonic dystrophy. Otol Neurotol 2005;26:310-11.
30. Hilton-Jones D. Myotonic dystrophy - forgotten aspects of an often neglected condition. Curr Opin Neurol 1997;10:399-401.
31. Kiliaridis S, Katsaros C. The effects of myotonic dystrophy and Duchenne muscular dystrophy on the orofacial muscles and dentofacial morphology. Acta Odontol Scand 1998;56:369-74.
32. van Engelen B, Brunner HG. Gastrointestinal dysfunction in myotonic dystrophy. In: Harper P, van Engelen B, Eymard B, eds. Myotonic dystrophy: present management, future therapy. Oxford: Oxford University Press, 2004:113-25.
33. Ronnblom A, Forsberg H, Danielsson A. Gastrointestinal symptoms in myotonic dystrophy. Scand J Gastroenterol 1996;31:654-7.
34. Eckardt VF, Nix W. The anal sphincter in patients with myotonic muscular dystrophy. Gastroenterology 1991;100:424-30.
35. Begin P, Mathieu J, Almirall J, et al. Relationship between chronic hypercapnia and inspiratory-muscle weakness in myotonic dystrophy. Am J Respir Crit Care Med 1997;156:133-9.
36. Zifko UA, Hahn AF, Remtulla H, et al. Central and peripheral respiratory electrophysiological studies in myotonic dystrophy. Brain 1996;119(Pt 6): 1911-22.
37. Finnimore AJ, Jackson RV, Morton A, et al. Sleep hypoxia in myotonic dystrophy and its correlation with awake respiratory function. Thorax 1994;49:66-70.
38. Bégin P, Laforte M, Beaudry M, et al. Sleep apnea and daytime respiratory function are associated with CTG repeat in myotonic dystrophy. Proceedings of the American Thoracic Association 2005:A674.
39. Nguyen HH, Wolfe JT III, Holmes DR Jr, et al. Pathology of the cardiac conduction system in myotonic dystrophy: a study of 12 cases. J Am Coll Cardiol 1988;11:662-71.
40. Bushby K, Muntoni F, Bourke JP. 107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th June 2002, Naarden, the Netherlands. Neuromuscul Disord 2003;13:166-72.
41. Johnson ER, Abresch RT, Carter GT, et al. Profiles of neuromuscular diseases. Myotonic dystrophy. Am J Phys Med Rehabil 1995;74(5 Suppl):S104-16.
42. Groh WJ, Lowe MR, Zipes DP. Severity of cardiac conduction involvement and arrhythmias in myotonic dystrophy type 1 correlates with age and CTG repeat length. J Cardiovasc Electrophysiol 2002;13:444-8.
43. Sabovic M, Medica I, Logar N, et al. Relation of CTG expansion and clinical variables to electrocardiogram conduction abnormalities and sudden death in patients with myotonic dystrophy. Neuromuscul Disord 2003;13:822-6.
44. O'Brien TA, Harper PS. Course, prognosis and complications of childhood-onset myotonic dystrophy. Dev Med Child Neurol 1984;26:62-7.
45. Mathieu J, Allard P, Potvin L, et al. A 10-year study of mortality in a cohort of patients with myotonic dystrophy. Neurology 1999;52:1658-62.
46. Johansson A, Henrrksson A, Olofsson BO, et al. Adrenal steroid dysregulation in dystrophia myotonica. J Intern Med 1999;245:345-51.
47. Gomez-Saez JM, Fernandez-Real JM, Navarro MA, et al. GH secretion status in myotonic dystrophy. Psychoneuroendocrinology 1993;18:183-90.
48. Johansson A, Ahren B, Forsberg H, et al. Testosterone and diurnal rhythmicity of leptin, TNF-alpha and TNF-II receptor in insulin-resistant myotonic dystrophy patients. Int J Obes Relat Metab Disord 2002;26:1386-92.
49. Fernandez-Real JM, Molina A, Broch M, et al. Tumor necrosis factor system activity is associated with insulin resistance and dyslipidemia in myotonic dystrophy. Diabetes 1999;48:1108-12.
50. Carter JN, Steinbeck KS. Reduced adrenal androgens in patients with myotonic dystrophy. J Clin Endocrinol Metab 1985;60:611-14.
51. Sakakibara R, Hattori T, Tojo M, et al. Micturitional disturbance in myotonic dystrophy. J Auton Nerv Syst 1995;52:17- 21.
52. Mathieu J, Boivin H, Richards CL. Quantitative motor assessment in myotonic dystrophy. Can J Neurol Sci 2003;30:129-36.
53. Nitz J, Burns Y, Jackson RV. Development of a reliable test of neck muscle strength and range in myotonic dystrophy subjects. Physiother Theory Pract 1995;11:239-44.
54. Ertekin C, Yuceyar N, Aydogdu I, et al. Electrophysiological evaluation of oropharyngeal swallowing in myotonic dystrophy. J Neurol Neurosurg Psychiatry 2001;70:363-71.
55. Mathieu J, De Braekeleer M, Prevost C, et al. Myotonic dystrophy: clinical assessment of muscular disability in an isolated population with presumed homogeneous mutation. Neurology 1992;42:203-8.
56. Phillips MF, Mathieu J. Physical disability in myotonic dystrophy. In: Harper P, Van Engelen B, Eymard B, et al, eds. Myotonic dystrophy: present management, future therapy. Oxford: Oxford Press University, 2004:68-82.
57. Wright RB, Yoder DM, Costa JL, et al. Characterization of gait parameters in adult-onset myotonic dystrophy: abnormal hip motion. Arch Phys Med Rehabil 1995;76:33-8.
58. Nitz J, Burns Y, Jackson R. The validity of button fastening as a test of hand disability in myotonic dystrophy. Aust J Physiother 1998;44:117-21.
59. Laberge L, Begin P, Montplaisir J, et al. Sleep complaints in patients with myotonic dystrophy. J Sleep Res 2004;13:95-100.
60. de Die-Smulders CE. Congenital and childhood-onset myotonic dystrophy. In: Harper P, van Engelen B, Eymard B, et al, eds. Myotonic dystrophy: present management, future therapy. Oxford: Oxford University Press, 2004:162-75.
61. Rubinsztein JS, Rubinsztein DC, Goodburn S, et al. Apathy and hypersomnia are common features of myotonic dystrophy. J Neurol Neurosurg Psychiatry 1998;64:510-15.
62. van der Werf S, Kalkman J, Bleijenberg G, et al. The relation between daytime sleepiness, fatigue, and reduced motivation in patients with adult onset myotonic dystrophy. J Neurol Neurosurg Psychiatry 2003;74:138-9.
63. Delaporte C. Personality patterns in patients with myotonic dystrophy. Arch Neurol 1998;55:635-40.
64. Verhagen WI, ter Bruggen JP, Huygen PL. Oculomotor, auditory, and vestibular responses in myotonic dystrophy. Arch Neurol 1992;49:954-60.
65. Mathieu J, Allard P, Gobeil G, et al. Anesthetic and surgical complications in 219 cases of myotonic dystrophy. Neurology 1997;49:1646-50.
66. Rudnik-Schöneborn S, de Die-Smulders CE. Pregnancy and perinatal problems in myotonic dystrophy. In: Harper P, Van Engelen BGM, Eymard B, et al, eds. Myotonic dystrophy:present management, future therapy. Oxford: Oxford University Press, 2004:153-61.
67. Rudnik-Schoneborn S, Zerres K. Outcome in pregnancies complicated by myotonic dystrophy: a study of 31 patients and review of the literature. Eur J Obstet Gynecol Reprod Biol 2004;114:44-53.
68. Dahlbom K, Ahlstrom G, Barany M, et al. Muscular dystrophy in adults: a five-year follow-up. Scand J Rehabil Med 1999;31:178-84.
69. Mathieu J, Jean S, Gagnon C, et al. Fatigue is linked to disease severity in myotonic dystrophy. J Sleep Res 2004;13(Suppl 1 ):1.
70. Laberge L, Bégin P, Richer L, et al. Fatigue and daytime sleepiness in patients with myotonic dystrophy type 1: to lump or split? Arch Neurol. In press.
71. Donze C, Delattre S, Viet G, et al. Neuromuscular disease: health care accessibility in the Nord-Pas-de- Calais region. Rev Neurol (Paris) 1999;155:1063-70.
72. Prevost C, Veillette S, Perron M, et al. Psychosocial impact of predictive testing for myotonic dystrophy type 1. Am J Med Genet A 2004;126:68-77.
73. Veillette S, Perron M, Desbiens F. La dystrophie myotonique: Étude épidémiologique et sociodémographique au Saguenay-Lac-St-Jean. Jonquière: Cégep de Jonquière, 1986.
74. Lord SM. Support groups for myotonic dystrophy and their role: an American family perspective. In: Harper P, van Engelen B, Eymard B, et al, eds. Myotonic aystrophy:present management, future therapy. Oxford: Oxford University Press, 2004.
75. van Hilten JJ, Kerkhof GA, van Dijk JG, et al. Disruption of sleep-wake rhythmicity and daytime sleepiness in myotonic dystrophy. J Neurol Sci 1993;114:68-75.
76. Nätterlund B, Ahlström G. Problem-focused coping and satisfaction with activities of daily living in individuals with muscular dystrophy and postpolio syndrome. Scand J Caring Sci 1999;13:26- 32.
77. de Die-Smulders CE, Howeler CJ, Thijs C, et al. Age and causes of death in adult-onset myotonic dystrophy. Brain 1998;121(Pt 8):1557-63.
78. Veillette S, Perron M, Mathieu J. Myotonic dystrophy: II. Marital status, fertility and gene transmission. Can J Neurol Sci 1989;16:114-18.
79. Veillette S, Perron M, Mathieu J, et al. Sociocultural factors influencing the spread of myotonic dystrophy in the Saguenay-Lac-St-Jean region of the province of Quebec (Canada). In: Roberts DF, Bittles AH, eds. Genetics, demography and health in minority populations. London: MacMillan, 1991:83-100.
80. Fowler WM Jr, Abresch RT, Koch TR, et al. Employment profiles in neuromuscular diseases. Am J Phys Med Rehabil 1997;76:26-37.
81. Marchini C, Lonigro R, Verriello L, et al. Correlations between individual clinical manifestations and CTG repeat amplification in myotonic dystrophy. Clin Genet 2000;57:74-82.
82. Lindeman E, Leffers P, Reulen J, et al. Quadriceps strength and timed motor performances in myotonic dystrophy, Charcot-Marie-Tooth disease, and healthy subjects. Clin Rehabil 1998;12:127-35.
83. Turnpenny P, Clark C, Kelly K. Intelligence quotient profile in myotonic dystrophy, intergenerational deficit, and correlation with CTG amplification. J Med Genet 1994;31:300-5.
84. Harper P. Myotonic dystrophy, 2nd edn. London: WB Saunders Co, 1989.
85. Phillips MF, Steer HM, Soldan JR, et al. Daytime somnolence in myotonic dystrophy. J Neurol 1999;246:275-82.
86. Hilton-Jones D, Damian M, Meola G. Somnolence and its management. In: Harper PS, Van Engelen BGM, Eymard B, et al, eds. Myotonic dystrophy: present management, future therapy. Oxford: Oxford University Press, 2004:135-49.
87. Chaudhuri A, Behan PO. Fatigue in neurological disorders. Lancet 2004;363:978-88.
88. Machuca-Tzili L, Brook D, Hilton-Jones D. Clinical and molecular aspects of the myotonic dystrophies: A review. Muscle Nerve 2005;32:1-18.
89. Portwood MM, Wicks JJ, Lieberman JS, et al. Psychometric evaluation in myotonic muscular dystrophy. Arch Phys Med Rehabil 1984;65:533-6.
90. Bassez G, Lazarus A, Desguerre I, et al. Severe cardiac arrhythmias in young patients with myotonic dystrophy type 1. Neurology 2004;63:1939-41.
91. Rogers MT, Mathieu J. Follow-up and assessment protocols for myotonic dystrophy. In: Harper P, van Engelen B, Eymard B, et al, eds. Myotonic dystrophy: present management, future therapy. Oxford: Oxford University Press, 2004:58-67.
92. Campbell H, Bradshaw N, Davidson R, et al. Evidence based medicine in practice: lessons from a Scottish clinical genetics project. J Med Genet 2000;37:684-91.
93. Rohrbach JI. Critical pathways as an essential part of a disease management program. J Nurs Care Qual 1999;14:11-15.
94. Taylor P. Comprehensive nursing case management. An advanced practice model. Nurs Case Manag 1999;4:2-10 (quiz 11-3).